Locating biobanks in the Canadian privacy maze

Journal of Law, Medicine and Ethics

Volumn 44, Issue 1, 2016, Pages 7-19

  Saulnier, Katie M ^a   Joly, Yann ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOBANK; CANADA; HUMAN; PRIVACY; RESEARCH ETHICS;

BIOLOGICAL SPECIMEN BANKS; CANADA; ETHICS, RESEARCH; HUMANS; PRIVACY;

EID: 85018818923     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1177/1073110516644185     Document Type: Article

References (52)

1. “Privacy: A Fundamental Right in Canada,” Health Canada, available at (last visited January 14, 2016)
2. “A Guide for Individuals Protecting Your Privacy,” OPC Guidance Documents, Office of the Privacy Commissioner of Canada, available at (last visited February 27, 2015)
3. T. Lemmens and L. Austin, “The End of Individual Control over Health Information: Promoting Fair Information Practices and Governance of Biobank Research,” in J. Kaye and M. Stranger, eds., Principles and Practice in Biobank Governance (University of Oxford, 2009) at 252, [The End of Individual Control].
4. U.S. Anti-Terrorism Legislation Takes Away Consent, “Carters’ Charity Law Bulletin No. 128, available at (last visited January 25, 2016).
5. Substantially Similar Provincial Legislation, “Office of the Privacy Commissioner of Canada, available at (last visited January 25, 2016).
6. Process for the Determination of “Substantially Similar,” Provincial Legislation by the Governor in Council, Office of the Privacy Commissioner of Canada, available at (last visited January 25, 2016)
7. An Act Respecting the Protection of Personal Information in the Private Sector, LRQ Chapter P-39.1 (1994)
8. “Questions and Answers regarding the application of PIPEDA, Alberta and British Columbia’s Personal Information Protection Acts,” Office of the Privacy Commissioner of Canada, available at (last visited January 25, 2016).
9. T. Caulfield, “Revisiting Core Principles: Autonomy, Consent, and the Biobanking Challenge,” in J. Downie and E. Gibson, eds., Health Law at the Supreme Court of Canada (Toronto: Irwin Law Inc., 2007) at 170.
10. U. Ogbogu, S. Burningham, and T. Caulfield, “The Right to Control and Access Genetic Research Information: Does McInerney Offer a Way Out of the Consent/Withdrawal Conundrum?” UBC Law Review 47, no. 1 (2014): 275-92.
11. “Piljak Estate v. Abraham: Is Excised Human Tissue Personal Property?” Hull & Hull LP, 2014, available at (last visited January 25, 2016)
12. Piljak Estate v. Abraham, 2014 ONSC 2893.
13. J. Wagner, “Property Rights and the Human Body” in Genomics Law Report, 2014, available at (last visited January 25, 2016).
14. “Canadian Tissue Repository Network: About Us,” available at (last visited January 25, 2016).
15. K. El Emam, “Methods for the De-identification of Electronic Health Records for Genomic Research,” Genome Medicine 3, no. 4 (2011) at 2, [Methods for the de-identification].
16. U. Ogbogu, S. Burningham, and A. Ollenberger et al., “Policy Recommendations for addressing Primary Challenges Associated with Cell-based Research and Interventions,” BMC Medical Ethics 15, no.2 (2014) at 3.
17. E. Lévesque and B.M. Knoppers, “Management Strategies for Ethics in International Research,” Current Genetic Medical Reports 2, no. 4 (2014): 255-260.
18. T. Caulfield, N. Ries, and G. Barr, “Variation in Ethics Review of Multi-Site Research Initiatives,” Amsterdam Law Forum 3, no. 1 (2011): 85-100.
19. P. Kossem, E. S. Dove, and C. Baggaley et al., “Building a Data Sharing Model for Global Genomic Research,” Genome Biology 15, no. 8 (2014):430-436 [Building a data sharing model].
20. “Frequently Asked Questions on the Commission’s Adequacy finding on the Canadian Personal Information Protection and Electronic Documents Act,” European Commission, available at (last visited February 27, 2015).
21. T. Banks, “Europe Not Yet Satisfied with Adequacy of Québec’s Privacy Law,” available at (last visited January 25, 2016).
22. “Opinion 7/2014 on the Protection of Personal Data in Quebec,” available at (last visited January 25, 2016).
23. D. J. Wilison, “Use of Data from the Electronic Health Record for Health Research-Current Governance Challenges and Potential Approaches,” commissioned by the Office of the Privacy Commissioner of Canada, 2009
24. E. S. Dove, B. M. Knoppers, and M. H. Zawati, “Towards an Ethics Safe Harbor for Global Biomedical Research,” Journal of Law and the Biosciences 1, no. 1 (2014): 3-51.
25. “Banking for the Future: “Informing” Consent in the Context of Biobanks,” Office of the Privacy Commissioner of Canada, available at (last visited January 25, 2016).
26. T. Lemmens and L. Austin, “Privacy, Consent, and Governance” in New Challenges for Biobanks: Ethics, Law and Governance, K. Dierickx and P. Borry, eds. (Antwerp/Portland, OR: Intersentia, 2009).
27. T. Caulfield and B. M. Knoppers, “Consent, Privacy & Research Biobanks,” Genome Canada 1, Policy Brief 7 (2010): 1.
28. K. S. Steinsbekk, B. K. Myskja, and B. Solberg, “Broad Consent versus Dynamic Consent in Biobank Research: Is Passive Participation an Ethical Problem?” European Journal of Human Genetics 21, no. 9 (2013): 97-902.
29. C. Allen, Y. Joly, and P. G. Moreno, “Data Sharing, Biobanks, and Informed Consent: A Research Paradox,” McGill Journal of Law and Health 7, no. 1 (2013): 85-120.
30. K. C. O’Doherty, A. K. Hawkins, and M. M. Burgess, “Involving Citizens in the Ethics of Biobank Research: Informing Institutional Policy through Structured Public Deliberation,” Social Science and Medicine 75, no. 9 (2012):1604-1611.
31. T. Caulfield, C. Rachul, and E. Nelson, “Biobanking, Consent, and Control: A Survey of Albertans on Key Research Ethics Issues,” Biopreservation and Biobanking 10, no. 5 (2012): 433-438.
32. Canadian Partnership for Tomorrow Project, available at (last visited January 25, 2016)
33. “Privacy and Confidentiality,” Canadian Partnership for Tomorrow Project, available at (last visited January 25, 2016).
34. “Consent Form: Second Wave of Recruitment of CARTaGENE,” CARTaGENE, available at (last visited January 25, 2016).
35. “Consent and Withdrawal,” BC Generations Project, available at , (last visited January 25, 2016).
36. The Tomorrow Project, available at , (last visited January 25, 2016)
37. “Public Notice: Genizon Biosciences Inc.,” Genome Québec, 2012, available at
38. K. Davies, “Quebec’s Genizon Biosciences Closes Its Doors,” available at (last visited January 25, 2016).
39. T. Caulfield, S. Burningham, and Y. Joly et al., “A Review of the Key Issues Associated with the Commercialization of Biobanks,” Journal of Law and the Biosciences (2014): 94-110, at 106.
40. PreThera Research, Networks of Centres of Excellence of Canada, available at (last visited January 25, 2016).
41. K. C. O’Doherty, M. M. Burgess, and K. Edwards et al., “From Consent to Institutions: Designing Adaptive Governance for Genomic Biobanks,” Social Science & Medicine 73, no. 3 (2011): 367-374.
42. R. Dalton, “Tribe Blasts ‘Exploitation’ of Blood Samples,” Nature 420, no. 6912 (2002): 111.
43. D. Steel, “Blood Taken for Research Destroyed,”.Ha-Shilth-Sa. 2008, available at (last visited February 27, 2015).
44. I. Mosby, “Administering Colonial Science: Nutrition Research and Human Biomedical Experimentation in Aboriginal Communities and Residential Schools, 1942-1952,” Social History, 46, no. 91 (2013):145-172
45. M. Castanello “Ethics of Aboriginal Research,” available at (last visited January 25, 2016)
46. L. Vogel, “Broken Trust Drives Native Health Disparities,” Canadian Medical Association Journal 187, no. 1 (2014):E9-E10
47. L. Vogel, “The New Ethics of Aboriginal Health Research,” Canadian Medical Association Journal (epub ahead of print).
48. “Genes, Patents, and Indigenous Peoples: Biomedical Research and Indigenous Peoples’ Rights,” Cultural Survival, available at (last visited January 25, 2016).
49. E.S. Dove, L. Black, D. Avard et al., “Charting the Privacy Landscape in Canadian Pediatric Biobanks,” Health Law Journal 20, no. 1 (2013):1-46.
50. E J. Samuel, B.M. Knoppers, and D. Avard, “Paediatric Biobanks: What Makes Them So Unique?,” Journal of Paediatrics and Child Health 48, no. 2 (2012):E1-E3.
51. E E.S. Dove, L. Black, D. Avard et al., “Privacy in Canadian Paediatric Biobanks: A Changing Landscape: A Report Delivered to the Privacy Commissioner of Canada,” Centre of Genomics and Policy, 2011.
52. D. Avard, L. Black, J. Samuël et al., “Best Practices for Health Research Involving Children and Adolescents,” Centre of Genomics and Policy (CGP), Maternal Infant Child and Youth Research Network (MICYRN), 2012.